{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:44:36Z","timestamp":1769845476958,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.earlhumdev.2019.104846","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T07:59:55Z","timestamp":1567065595000},"page":"104846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Screening and novel therapies for retinopathy of prematurity \u2013 A review"],"prefix":"10.1016","volume":"138","author":[{"given":"Ann","family":"Hellstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lena","family":"H\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.earlhumdev.2019.104846_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0010","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/jama.2019.2021","article-title":"Association between year of birth and 1-year survival among extremely preterm infants in Sweden during 2004\u20132007 and 2014\u20132016","volume":"321","author":"Norman","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/aos.13549","article-title":"Increased frequency of retinopathy of prematurity over the last decade and significant regional differences","volume":"96","author":"Holmstrom","year":"2018","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpeds.2016.04.083","article-title":"Neonatal outcomes of very low birth weight and very preterm neonates: an international comparison","volume":"177","author":"Shah","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bjophthalmol-2017-310709","article-title":"A worldwide survey of retinopathy of prematurity screening","volume":"102","author":"Mora","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02583285","article-title":"Towards a universal approach for screening of retinopathy of prematurity (ROP)","volume":"92","author":"Schalij-Delfos","year":"1996","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000085295","article-title":"Can screening for retinopathy of prematurity be reduced?","volume":"88","author":"Termote","year":"2005","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/eye.2011.334","article-title":"A predictive score for retinopathy of prematurity in very low birth weight preterm infants","volume":"26","author":"Eckert","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0045","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"Lofqvist","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0050","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstrom","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/archophthalmol.2012.243","article-title":"Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity","volume":"130","author":"Wu","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apa.14049","article-title":"Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity","volume":"107","author":"Lundgren","year":"2018","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0065","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1542\/peds.2010-2240","article-title":"A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain","volume":"127","author":"Binenbaum","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0070","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archophthalmol.2012.2524","article-title":"The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model","volume":"130","author":"Binenbaum","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaapos.2015.10.017","article-title":"The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm","volume":"20","author":"Cao","year":"2016","journal-title":"J AAPOS"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3928\/01913913-20180405-02","article-title":"Implementation of a clinical prediction model using daily postnatal weight gain, birth weight, and gestational age to risk stratify ROP","volume":"55","author":"McCauley","year":"2018","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"19","key":"10.1016\/j.earlhumdev.2019.104846_bb0090","first-page":"30138-2","article-title":"Retrospective validation of the postnatal Growth and Retinopathy of Prematurity (G-ROP) criteria in a Japanese cohort","volume":"9394","author":"Shiraki","year":"2019","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaophthalmol.2017.2295","article-title":"Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) model","volume":"135","author":"Binenbaum","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaophthalmol.2018.0376","article-title":"Validation of the Colorado Retinopathy of Prematurity screening model","volume":"136","author":"McCourt","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0105","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00018-013-1283-7","article-title":"VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration","volume":"70","author":"Carmeliet","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0110","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2147\/OPTH.S161504","article-title":"Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists","volume":"12","author":"Fouzdar Jain","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00417-017-3878-4","article-title":"Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity","volume":"256","author":"Huang","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0125","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcjo.2018.05.005","article-title":"Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre","volume":"54","author":"Isaza","year":"2019","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0140","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/bjo.2008.141481","article-title":"Anti-vascular endothelial growth factor and retinopathy of prematurity","volume":"92","author":"Sears","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0145","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0150","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00417-015-2996-0","article-title":"Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab","volume":"254","author":"Zhou","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0155","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between oxygen saturation targeting and death or disability in extremely preterm infants in the neonatal oxygenation prospective meta-analysis collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0160","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1203\/00006450-199412000-00007","article-title":"Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat","volume":"36","author":"Penn","year":"1994","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0165","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(95)92475-2","article-title":"Transcutaneous oxygen levels in retinopathy of prematurity","volume":"346","author":"Cunningham","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1542\/peds.111.2.339","article-title":"Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?","volume":"111","author":"Chow","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0175","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1542\/peds.2013-1834","article-title":"Closed-loop automatic oxygen control (CLAC) in preterm infants: a randomized controlled trial","volume":"133","author":"Hallenberger","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.105.2.295","volume":"105","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0185","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1542\/peds.2009-2218","article-title":"High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis","volume":"125","author":"Chen","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0190","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/pr.2016.98","article-title":"Graded oxygen saturation targets and retinopathy of prematurity in extremely preterm infants","volume":"80","author":"Cayabyab","year":"2016","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0195","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pedneo.2016.03.009","article-title":"Red blood cell transfusion and clinical outcomes in extremely low birth weight preterm infants","volume":"58","author":"Wang","year":"2017","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0200","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/eye.2017.76","article-title":"Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: a pilot prospective cohort study","volume":"31","author":"Stutchfield","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.1976.tb01877.x","article-title":"The pattern of fetal haemoglobin disappearance after birth","volume":"32","author":"Colombo","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0004563217721253","article-title":"Foetal haemoglobin concentration at postmenstrual age is unaffected by gestational age at birth","volume":"55","author":"Watanabe","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1537-2995.2012.03908.x","article-title":"A mathematical modeling approach to quantify the role of phlebotomy losses and need for transfusions in neonatal anemia","volume":"53","author":"Rosebraugh","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0220","unstructured":"Hellstr\u00f6m W, Forssell L, Morsing E, S\u00e4vman K, Ley D. Sampling-related blood loss replaced with adult blood transfusions might affect morbidity in extremely preterm infants. In Revision in Acta Paed."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0225","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/trf.12998","article-title":"Temporal changes in blood product usage in preterm neonates born at less than 30\u202fweeks' gestation in Canada","volume":"55","author":"Keir","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2017.10.231","article-title":"Delayed vs early umbilical cord clamping for preterm infants: a systematic review and meta-analysis","volume":"218","author":"Fogarty","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0235","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/vox.12720","article-title":"Umbilical cord blood as a source for red-blood-cell transfusion in neonatology: a systematic review","volume":"113","author":"Bianchi","year":"2018","journal-title":"Vox Sang."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0240","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1651-2227.2011.02389.x","article-title":"Improved growth of preterm infants receiving mother's own raw milk compared with pasteurized donor milk","volume":"100","author":"Montjaux-Regis","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1542\/peds.2004-1974","article-title":"Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants","volume":"116","author":"Schanler","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0250","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.clinthera.2017.05.341","article-title":"Effects of donor breastmilk feeding on growth and early neurodevelopmental outcomes in preterm infants: an observational study","volume":"39","author":"Madore","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/MPG.0000000000001959","article-title":"Dose-response relationship between donor human milk, mother's own milk, preterm formula, and neonatal growth outcomes","volume":"67","author":"Brownell","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/apa.14702","article-title":"Review shows that donor milk does not promote the growth and development of preterm infants as well as maternal milk","volume":"108","author":"Hard","year":"2019","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0265","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstrom","year":"2016","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpeds.2018.10.033","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","volume":"206","author":"Ley","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0275","doi-asserted-by":"crossref","first-page":"69ra12","DOI":"10.1126\/scitranslmed.3001571","article-title":"5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of {omega}-3 polyunsaturated fatty acids","volume":"3","author":"Sapieha","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0280","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0285","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s00394-015-1036-5","article-title":"Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia","volume":"55","author":"Bernhard","year":"2016","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0290","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0148607113499373","article-title":"Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study","volume":"38","author":"Pawlik","year":"2013","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","article-title":"Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial","volume":"20","author":"Najm","year":"2017","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jamaophthalmol.2017.6658","article-title":"Association of retinopathy of prematurity with low levels of arachidonic acid: a secondary analysis of a randomized clinical trial","volume":"136","author":"Lofqvist","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0305","first-page":"1","article-title":"Enteral docosahexaenoic acid and retinopathy of prematurity: a randomized clinical trial","volume":"0","author":"Bernabe-Garcia","year":"2019","journal-title":"J. Parenter. Enter. Nutr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0310","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0315","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.earlhumdev.2019.104846_bb0320","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021749","article-title":"Oral propranolol for prevention of threshold retinopathy of prematurity (ROPROP): protocol of a randomised controlled trial","volume":"8","author":"Buhrer","year":"2018","journal-title":"BMJ Open"}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378219304864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378219304864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T01:57:46Z","timestamp":1759888666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378219304864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":64,"alternative-id":["S0378378219304864"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2019.104846","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and novel therapies for retinopathy of prematurity \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2019.104846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104846"}}